Larry D Lynd
Overview
Explore the profile of Larry D Lynd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
162
Citations
1750
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borle K, Austin J, Lynd L
Eur J Hum Genet
. 2025 Mar;
PMID: 40065012
Understanding the prevalence and distribution of unmet need for genetic counseling (GC) can help inform health human resource planning. It is known that not all patients who could benefit from...
2.
Jia A, Kuramoto L, Khakban A, Sio W, Traboulsee A, De Vera M, et al.
BMJ Open
. 2025 Jan;
15(1):e088924.
PMID: 39855661
Introduction: Long-term population-based safety studies, applying advanced causal inference techniques, including an active comparator with new-user design, are needed to investigate skin cancer outcomes among individuals with multiple sclerosis (MS)...
3.
Regier D, Loewen R, Chan B, Ehman M, Pollard S, Friedman J, et al.
Genet Med
. 2024 Jan;
26(4):101069.
PMID: 38205742
Purpose: To determine real-world diagnostic rates, cost trajectories, and cost-effectiveness of exome sequencing (ES) and genome sequencing (GS) for children with developmental and/or seizure disorders in British Columbia, Canada. Methods:...
4.
Salmasi S, Safari A, De Vera M, Hogg T, Lynd L, Koehoorn M, et al.
J Thromb Thrombolysis
. 2023 Dec;
57(3):437-444.
PMID: 38103148
Our objectives were to measure long-term adherence to oral anticoagulants (OACs) in patients with atrial fibrillation (AF) and to identify patient factors associated with adherence. Using linked, population-based administrative data...
5.
Greenfield J, Metz L, Khakban A, Llorian E, Michaux K, Traboulsee A, et al.
Mult Scler Relat Disord
. 2023 Nov;
80:105091.
PMID: 37924714
Background: Long-term population-based safety studies are needed to investigate cancer outcomes in people with multiple sclerosis (MS) treated with modern disease-modifying therapy (DMT). Objectives: To investigate if exposure to DMT...
6.
Mohammadi T, Guh D, Tam A, Pataky R, Black P, So A, et al.
Cancer Med
. 2023 Sep;
12(19):20106-20118.
PMID: 37740609
Background: The current prostate cancer (PCa) screening standard of care (SOC) leads to unnecessary biopsies and overtreatment because decisions are guided by prostate-specific antigen (PSA) levels, which have low specificity...
7.
Ahmadian S, Johnson K, Ho J, Sin D, Lynd L, Harrison M, et al.
Ann Am Thorac Soc
. 2023 Sep;
20(12):1735-1742.
PMID: 37703432
Daily oral azithromycin therapy can reduce the risk of acute exacerbations of chronic obstructive pulmonary disease (COPD). However, given its adverse events and additional costs, it is not known whether...
8.
Amegadzie J, Lee T, Sadatsafavi M, Lynd L, Sin D, Johnson K
CMAJ
. 2023 Sep;
195(35):E1172-E1179.
PMID: 37696554
Background: Chronic obstructive pulmonary disease (COPD) is an ambulatory care-sensitive condition, and the rate of hospital admissions for COPD is an indicator of the quality of outpatient care. We sought...
9.
Dragojlovic N, Borle K, Kopac N, Nisselle A, Nuk J, Jevon M, et al.
Curr Oncol
. 2023 Aug;
30(8):7241-7251.
PMID: 37623006
Over the last decade, utilization of clinical genetics services has grown rapidly, putting increasing pressure on the workforce available to deliver genetic healthcare. To highlight the policy challenges facing Canadian...
10.
Borle K, Kopac N, Dragojlovic N, Llorian E, Lynd L
Clin Ther
. 2023 Jul;
45(8):695-701.
PMID: 37516568
Rapid growth in the volume of referrals to clinical genetics services in many countries during the past 15 years makes workforce planning a critical policy tool in ensuring that the...